FIG. 4.
Detection of total immunoglobulin bound on the exterior surface membrane of mammary adenocarcinoma SKBr-3 monolayer populations as a function of increasing covalent epirubicin-(C3-amide)-[anti-HER2/neu] immunochemotherapeutic concentration. Covalent epirubicin-(C3-amide)-[anti-HER2/neu] immunochemotherapeutic. Monolayers of mammary adenocarcinoma SKBr-3 were incubated with covalent epirubicin-(C3-amide)-[anti-HER2/neu] immunochemotherapeutic over a 4-hour period and then total immunoglobulin bound on the exterior surface membrane was detected by cell-ELISA analysis.